I am thrilled to announce our six presenting LaunchPad SBDC Companies at Octane’s 2nd Annual Aesthetics Tech Summit, which will take place on January 20-22, 2021. These companies have been selected from a large pool of applicants who have recently been through the LaunchPad SBDC evaluation process and represent a diverse group of innovative aesthetics technology companies. Each of these six companies has the potential to change the future of medical aesthetics. Please join me in congratulating the 6 companies below. Learn more and register for the event here.
Candesant- Candesant Biomedical is developing a novel approach to energy production – Targeted Alkali Thermolysis (TAT) – for the non-invasive treatment for excessive sweating. Candesant’s lead product is a topical patch to treat excessive sweating with a quick, in-office procedure. The technology is based on the principle that alkali metals, in contact with water, generate thermal energy. Two successful clinical studies demonstrated efficacy in reducing sweat and validated that the energy is reproducibly generated, highly targeted and inactivates the most active sweat glands. In these studies, TAT demonstrated significant sweat reduction benefits lasting up to 2 months after a single, no down-time treatment.
Hallura- Hallura new HA dermal fillers platform has the potential to become the best-in-class solution, taking a significant market share of the 3B$ filler market. Hallura’s unique and patented technology is a scientific breakthrough allowing to break the paradigm of the conflicting demand for strong lifting effect, safe and comfortable procedure with natural and soft aesthetic results. It will significantly improve the customer experience and expand the market. A clinical trial is already under recruitment in Europe (Phase III) with a target market launch in 2022. Hallura has a clear regulatory and clinical path toward clearance in the USA.
PB&B- PB&B is a Swiss Life Sciences startup developing a novel injectable technology to enhance fat volume (in situ) with lipids. Developed by an international team of doctors and bioengineers - clinical testing for mid-facial volume loss is set to begin in April 2021 towards an FDA approval + CE mark expected by 2023. PB&B has won numerous R&D innovation grants and international awards including the IMCAS Innovation of the year award 2018.
Pomp Beauty- Pomp clients complete an online skin survey that is sent to a licensed aesthetician who will follow up via text for a virtual skin consultation. Clients can upload a photo of their skin and the aesthetician makes skincare product recommendations that are unique to each individual. Products are placed in the client's cart where they can checkout and reorder via Pomp. Pomp monetizes on each transaction when a customer orders, collecting an average 50% gross margin from partner brands such as iSClinical and Revision. Pomp works with aestheticians to help bring awareness to this community nationwide. Our aestheticians are independent contractors and receive a commission on all sales.
R2 Technologies- R2 Technologies is a world leader in CryoAesthetic™ medical devices. Headquartered in Silicon Valley, R2 focuses on the development and commercialization of groundbreaking technologies for aesthetic providers and consumers.
You can register for Aesthetics Tech Summit here